DEEP-Lung-IV Video Interview

SOPHiA GENETICS’s DEEP-Lung-IV (NCT04994795), a multicentric and multimodal real-world data observational study, is focused on unraveling predictive signatures linked with immunotherapy treatment responses and prognosis in stage IV NSCLC patients. We are excited to share our recent interview with Prof. Jacques Cadranel and Prof. Sébastien Couraud, where you can learn more about how multimodal data integration is advancing personalized medicine in lung cancer. Learn more on our website: https://www.sophiagenetics.com/sophia-ddm-for-multimodal/deep-lung-iv/